Turn Therapeutics Inc. (TTRX)

Turn Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Selling, General & Admin	-	1.55	2.3
Research & Development	-	0.25	0.01
Operating Expenses	-	1.8	2.31
Operating Income	-2.75	-1.8	-2.31
Interest Expense / Income	-0.02	-0.03	-0.02
Pretax Income	-2.56	-1.77	-2.29
Net Income	-2.56	-1.77	-2.29
Free Cash Flow	-1.69	-1.46	-1.42
EBITDA	-2.53	-1.75	-2.26
Depreciation & Amortization	0.05	0.05	0.04
EBIT	-2.58	-1.8	-2.31

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).